Citation Impact
Citing Papers
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
2009 Standout
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Malignant pheochromocytoma: current status and initiatives for future progress
2004
Auditory verbal hallucinations and dysfunction of the neural substrates of speech
2001
Current Approaches to Primary Therapy for Papillary and Follicular Thyroid Cancer
2001 Standout
Impact of cervical lymph node dissection on serum TG and the course of disease in TG-positive, radioactive iodine whole body scan-negative recurrent/persistent papillary thyroid cancer
2002
Phaeochromocytoma
2005 Standout
The management of benign and malignant pheochromocytoma and abdominal paraganglioma
2003
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
The hallucinating brain: A review of structural and functional neuroimaging studies of hallucinations
2007 Standout
Outcome in patients with differentiated thyroid cancer with negative diagnostic whole-body scanning and detectable stimulated thyroglobulin
2003
Undetectable Thyroglobulin in Patients With Differentiated Thyroid Carcinoma and Residual Radioiodine Uptake on a Postablation Whole-Body Scan
2011
Recent advances in radiological and radionuclide imaging and therapy of neuroendocrine tumours
2004
Radiopharmaceutical Treatment of Pheochromocytomas
2002
Cervicomediastinal Magnetic Resonance Imaging in Persistent or Recurrent Papillary Thyroid Carcinoma: Clinical Use and Limits
1999
Recurrent/metastatic thyroid carcinomas false negative for serum thyroglobulin but positive by posttherapy I-131 whole body scans
2008
Evolving Concepts in the Pathophysiology, Diagnosis, and Treatment of Pheochromocytoma
1994
High‐dose 131I‐metaiodobenzylguanidine therapy for 12 patients with malignant pheochromocytoma
2003
SERUM THYROGLOBULIN MEASUREMENT
2001
Pheochromocytoma: Update on Diagnosis, Localization, and Management
1995
Surveillance of patients to detect recurrent thyroid carcinoma
1999
Management of Patients with Scan Negative, Thyroglobulin Positive Differentiated Thyroid Carcinoma
1998
Diagnostic value of serum thyroglobulin measurements in the follow‐up of differentiated thyroid carcinoma, a structured meta‐analysis
2004
Pheochromocytoma: 1926–1993
1993
Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma
2015 Standout
Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Taskforce
2006 Standout
Medullary Thyroid Cancer: Management Guidelines of the American Thyroid Association
2009 Standout
Sequential Follow-up of Serum Thyroglobulin and Whole Body Scan in Thyroid Cancer Patients without Initial Metastasis
2006
Value of Postoperative Thyroglobulin and Ultrasonography for the Indication of Ablation and 131 I Activity in Patients with Thyroid Cancer and Low Risk of Recurrence
2010
The follow-up of patients with differentiated thyroid cancer and undetectable thyroglobulin (Tg) and Tg antibodies during ablation
2008
Is empiric 131I therapy justified for patients with positive thyroglobulin and negative 131I whole-body scanning results?
2005
Thyroglobulin determination, neck ultrasonography and iodine-131 whole-body scintigraphy in differentiated thyroid carcinoma.
1996
The Diagnosis and Medical Management of Advanced Neuroendocrine Tumors
2004
Comparison of (18)F-FDG, (131)I-Na, and (201)Tl in diagnosis of recurrent or metastatic thyroid carcinoma.
2001
Radioiodine therapy for differentiated thyroid carcinoma with thyroglobulin positive and radioactive iodine negative metastases
2009
Papillary thyroid cancer with chest metastases only detected using radioactive iodine.
2004
Benign and Malignant Pheochromocytoma
1998
Guidelines for the management of thyroid cancer
2014 Standout
Thyroid carcinoma
2003 Standout
Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline
2014 Standout
Works of A Brendel being referenced
Radionuclide Therapy of Pheochromocytomas and Neuroblastomas Using lodine-131 Metaiodobenzylguanidine (MIBG)
1989
Use ofm-[131I]Iodobenzylguanidine in the Treatment of Malignant Pheochromocytoma
1991
Low levels of serum thyroglobulin after withdrawal of thyroid suppression therapy in the follow up of differentiated thyroid carcinoma
1990
Thallium-201 imaging in the follow-up of differentiated thyroid carcinoma.
1988
Treatment of malignant pheochromocytoma with [131I]metaiodobenzylguanidine: a French multicenter study.
1992